Bristol Myers Squibb (BMY) Operating Income (2009 - 2026)
Bristol Myers Squibb's Operating Income was $2.54 billion in Q3 2026, down 18.6% from $3.11 billion a year earlier and down 37.9% from the prior quarter.
Bristol Myers Squibb (BMY) Operating Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bristol Myers Squibb's Operating Income was $11.33 billion through Sep 30, 2026, up 41.1% year-over-year; for FY2025, it came in at $9.33 billion.
- In earlier years, Operating Income was -$8.38 billion in FY2024, $8.44 billion in FY2023 (+9.4%), $7.71 billion in FY2022 (-4.8%) and $8.1 billion in FY2021.
- Quarterly Operating Income has moved between -$11.52 billion (Q1 2024) and $4.09 billion (Q2 2026) over five years.
- Compared with a year earlier, Operating Income was higher in five of the last seven quarters, with growth averaging 127.9%.
- The best year-over-year quarter for Operating Income over five years was Q4 2025 (growth of 740.0%); the worst was Q4 2024 (a decline of 89.5%).
- Per Business Quant data, BMY's Operating Income in the three quarters before Q3 2026 was $4.09 billion (Q2 2026), $3.24 billion (Q1 2026) and $1.47 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 2.54 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.54 Bn |
| Jun 30, 2026 | 4.09 Bn |
| Mar 31, 2026 | 3.24 Bn |
| Dec 31, 2025 | 1.47 Bn |
| Sep 30, 2025 | 3.11 Bn |
| Jun 30, 2025 | 1.77 Bn |
| Mar 31, 2025 | 2.97 Bn |
| Dec 31, 2024 | 175.00 Mn |
| Sep 30, 2024 | 1.68 Bn |
| Jun 30, 2024 | 1.29 Bn |
| Mar 31, 2024 | -11.52 Bn |
| Dec 31, 2023 | 1.67 Bn |
| Sep 30, 2023 | 2.14 Bn |
| Jun 30, 2023 | 1.86 Bn |
| Mar 31, 2023 | 2.77 Bn |
| Dec 31, 2022 | 1.86 Bn |
| Sep 30, 2022 | 2.21 Bn |
| Jun 30, 2022 | 1.96 Bn |
| Mar 31, 2022 | 1.69 Bn |
| Dec 31, 2021 | 1.86 Bn |
Bristol Myers Squibb Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();